Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series.

NCT05008016 — Completed, 582 participants, Mohammed VI University Hospital

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Procalcitonin Level and the High Risk of Mortality in 30 Days , in Critically Ill Patients Infected by SARS-CoV-2, Experience of a North African Hospital University , Cases Series.

Registry	NCT05008016
Status	Completed
Study type	Observational
Enrollment	582 (Actual)
Sponsor	Mohammed VI University Hospital (Other)
Conditions	the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients
Dates	start 2020-01-01, primary completion 2020-01-01, completion 2021-01-31, first posted 2021-08-17, last updated 2021-08-17
Locations	1 site in Morocco

-Summary

Background:

Procalcitonin (PCT) is a biomarker that has been proposed as a helpful tool in inflammatory Clinique cases specially patient with pulmonary bacterienne infection .

Materials and methods the investigatore had retrospectively reviewed the electronic records and lists of all 582 COVID-19 patients admitted on the ICU of Hospital university Mohammed VI , Oujda. Between 01 juin 2020 and 31juanary 2021 , and analyzed the relation of PCT value and mortality at 30 days until we can defined a cut off Procalcitonine to use as a marker of severity and high mortality .

Expand all sections · Collapse all

+Detailed description

Our objective is to assess the relationship between Procalcitonin and 30-day mortality in patients admitted to the resuscitation department of the Mohammed VI University Hospital Center, Oujda, Morocco, infected by the SARS COV 2 Virus .

+Arms and interventions

Arm	Type	Interventions	Description
Procalcitonine analysed			The invistagatore had analysed the Procalcitonine of patient that survived and the non Survived frome COVID infection in Intensive care departement

+Outcome measures

Primary outcomes

Procalcitonin is a marker of mortality [through study completion, an average of 8 mounths]: as a cutoff 0.5 ng/ml Procalcitonin could be used as mortality factors

+Eligibility

Sex: All, ages: 15 Years to any

Inclusion Criteria:

* Clinical diagnosis of SARS COV2 infection needed admission in ICU .

Exclusion Criteria:

* patient under 15 ans

+Locations (1)

Facility	City	Country	Status
younes Oujidi	Berkane	Morocco